chrX-100599027-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_022144.3(TNMD):āc.589C>Gā(p.Gln197Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000335 in 1,193,384 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_022144.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 110957Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33207
GnomAD3 exomes AF: 0.00000601 AC: 1AN: 166516Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 52822
GnomAD4 exome AF: 0.00000185 AC: 2AN: 1082427Hom.: 0 Cov.: 29 AF XY: 0.00000286 AC XY: 1AN XY: 350019
GnomAD4 genome AF: 0.0000180 AC: 2AN: 110957Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33207
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.589C>G (p.Q197E) alteration is located in exon 6 (coding exon 6) of the TNMD gene. This alteration results from a C to G substitution at nucleotide position 589, causing the glutamine (Q) at amino acid position 197 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at